The global Lipidomics Analysis Service market is projected to grow from US$ 193 million in 2024 to US$ 222 million by 2031, at a CAGR of 2.1% (2025-2031), driven by critical product segments and diverse end‑use applications.

Lipidomics Analysis Service Market

Lipidomics analysis service is a professional service that comprehensively focuses on the analysis of molecular species, structure and function in biological samples. Through high-resolution mass spectrometry (such as LC-MS/MS) and advanced bioinformatics tools, this service can identify and quantify molecules, revealing their role in biological dependence, cell signaling and disease mechanisms. Lipidomics analysis covers multiple areas of dependency, including phospholipids, phospholipids, sphingolipids and obesity molecules.

From a downstream perspective, Disease Research accounted for % of 2024 revenue, surging to US$ million by 2031 (CAGR: % from 2025–2031).

Lipidomics Analysis Service leading manufacturers including INOMIXO, Lipotype, Mtoz Biolabs, Creative Proteomics, MetwareBio, AxisPharm, General Metabolics, BGI Genomics, Cambridge Bioscience, CD Genomics, etc., dominate supply; the top five capture approximately % of global revenue, with INOMIXO leading 2024 sales at US$ million.

Regional Outlook:

North America rose from US$ million in 2024 to a forecast US$ million by 2031 (CAGR %).

Asia‑Pacific will expand from US$ million to US$ million (CAGR  %), led by China (US$ million in 2024, % share rising to % by 2031), Japan (CAGR %), South Korea (CAGR %), and Southeast Asia (CAGR %).

Europe is set to grow from US$ million to US$ million (CAGR %), with Germany projected to hit US$ million by 2031 (CAGR %).

Report Includes:

This definitive report equips CEOs, marketing directors, and investors with a 360° view of the global Lipidomics Analysis Service market across value chain. It analyzes historical revenue data (2020–2024) and delivers forecasts through 2031, illuminating demand trends and growth drivers.

By segmenting the market by Type and by Application, the study quantifies market size, growth rates, niche opportunities, and substitution risks, and analyzes downstream customers distribution pattern.

Granular regional insights cover five major markets—North America, Europe, APAC, South America, and MEA—with in‑depth analysis of 20+ countries, detailing dominant products, competitive landscape, and downstream demand trends.

Critical competitive intelligence profiles players—revenue, margins, pricing strategies, and major customers—and dissects the top-player positioning across product lines, applications, and regions to reveal strategic strengths.

A concise Industry‑chain overview maps upstream, middlestream, and downstream distribution dynamics to identify strategic gaps and unmet demand.

Market Segmentation

Scope of Lipidomics Analysis Service Market Report

Report Metric	Details
Report Name	Lipidomics Analysis Service Market
Accounted market size in 2024	US$ 193 million
Forecasted market size in 2031	US$ 222 million
CAGR	2.1%
Base Year	2024
Forecasted years	2025 - 2031
Segment by Type	Targeted Lipidomics Non-targeted Lipidomics
Segment by Application	Disease Research Drug Development Others
Sales by Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Rest of Europe Nordic Countries Asia-Pacific (China, Japan, South Korea) Southeast Asia (India, Australia) Rest of Asia Latin America (Mexico, Brazil) Rest of Latin America Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company	INOMIXO, Lipotype, Mtoz Biolabs, Creative Proteomics, MetwareBio, AxisPharm, General Metabolics, BGI Genomics, Cambridge Bioscience, CD Genomics
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Defines the Lipidomics Analysis Service study scope, segments the market by Type and by Application, etc, highlights segment size and growth potential.
Chapter 2: Offers current market state, projects global revenue and sales to 2031, pinpointing high consumption regions and emerging market catalysts
Chapter 3: Dissects the player landscape—ranks by revenue and profitability, details Player performance by product type and evaluates concentration alongside M&A moves.
Chapter 4: Unlocks high margin product segments—compares revenue, ASP, and technology differentiators, highlighting growth niches and substitution risks
Chapter 5: Targets downstream market opportunities—evaluates market size by Application, identifies emerging use cases, and profiles leading customers by region and by Application.
Chapter 6: North America—breaks down market size by Type, by Application and country, profiles key players and assesses growth drivers and barriers.
Chapter 7: Europe—analyses regional market by Type, by Application and players, flagging drivers and barriers.
Chapter 8: Asia Pacific—quantifies market size by Type, by Application, and region/country, profiles top players, and uncovers high potential expansion areas.
Chapter 9: Central & South America—measures market size by Type, by Application, and country, profiles top players, and identifies investment opportunities and challenges.
Chapter 10: Middle East and Africa—evaluates market size by Type, by Application, and country, profiles key players, and outlines investment prospects and market hurdles
Chapter 11: Profiles players in depth—details product specs, revenue, margins; Top-tier players 2024 sales breakdowns by Product type, by Application, by region SWOT analysis, and recent strategic developments.
Chapter 12: Industry chain—analyses upstream, cost drivers, plus downstream channels.
Chapter 13: Market dynamics—explores drivers, restraints, regulatory impacts, and risk mitigation strategies.
Chapter 14: Actionable conclusions and strategic recommendations.
Why This Report:
Beyond standard market data, this analysis provides a clear profitability roadmap—empowering you to:
Allocate capital strategically to high growth regions (Chapters 6–10) and margin rich segments (Chapter 5).
Negotiate from strength with suppliers (Chapter 12) and customers (Chapter 5) using cost and demand intelligence.
Outmaneuver competitors with granular insights into their operations, margins, and strategies (Chapters 3 and 11).
Capitalize on the projected billion‑dollar opportunity with data‑driven regional and segment tactics (Chapter 12-14).
Leverage this 360° intelligence to turn market complexity into actionable competitive advantage.

FAQ for this report

How fast is Lipidomics Analysis Service Market growing?

Ans: The Lipidomics Analysis Service Market witnessing a CAGR of 2.1% during the forecast period 2025-2031.

What is the Lipidomics Analysis Service Market size in 2031?

Ans: The Lipidomics Analysis Service Market size in 2031 will be US$ 222 million.

Who are the main players in the Lipidomics Analysis Service Market report?

Ans: The main players in the Lipidomics Analysis Service Market are INOMIXO, Lipotype, Mtoz Biolabs, Creative Proteomics, MetwareBio, AxisPharm, General Metabolics, BGI Genomics, Cambridge Bioscience, CD Genomics

What are the Application segmentation covered in the Lipidomics Analysis Service Market report?

Ans: The Applications covered in the Lipidomics Analysis Service Market report are Disease Research, Drug Development, Others

What are the Type segmentation covered in the Lipidomics Analysis Service Market report?

Ans: The Types covered in the Lipidomics Analysis Service Market report are Targeted Lipidomics, Non-targeted Lipidomics

1 Study Coverage

1.1 Introduction to Lipidomics Analysis Service: Definition, Properties, and Key Attributes

1.2 Market Segmentation by Type

1.2.1 Global Lipidomics Analysis Service Market Size by Type, 2020 VS 2024 VS 2031

1.2.2 Targeted Lipidomics

1.2.3 Non-targeted Lipidomics

1.3 Market Segmentation by Application

1.3.1 Global Lipidomics Analysis Service Market Size by Application, 2020 VS 2024 VS 2031

1.3.2 Disease Research

1.3.3 Drug Development

1.3.4 Others

1.4 Assumptions and Limitations

1.5 Study Objectives

1.6 Years Considered

2 Executive Summary

2.1 Global Lipidomics Analysis Service Revenue Estimates and Forecasts 2020-2031

2.2 Global Lipidomics Analysis Service Revenue by Region

2.2.1 Revenue Comparison: 2020 VS 2024 VS 2031

2.2.2 Historical and Forecasted Revenue by Region (2020-2031)

2.2.3 Global Revenue Market Share by Region (2020-2031)

2.2.4 Emerging Market Focus: Growth Drivers & Investment Trends

3 Competition by Players

3.1 Global Lipidomics Analysis Service Player Revenue Rankings and Profitability

3.1.1 Global Revenue (Value) by Players (2020-2025)

3.1.2 Global Key Player Revenue Ranking (2023 vs. 2024)

3.1.3 Revenue-Based Tier Segmentation (Tier 1, Tier 2, and Tier 3)

3.1.4 Gross Margin by Top Player (2020 VS 2024)

3.2 Global Lipidomics Analysis Service Companies Headquarters and Service Footprint

3.3 Main Product Type Market Size by Players

3.3.1 Targeted Lipidomics Market Size by Players

3.3.2 Non-targeted Lipidomics Market Size by Players

3.4 Global Lipidomics Analysis Service Market Concentration and Dynamics

3.4.1 Global Market Concentration (CR5 and HHI)

3.4.2 Entrant/Exit Impact Analysis

3.4.3 Strategic Moves: M&A, Expansion, R&D Investment

4 Global Product Segmentation Analysis

4.1 Global Lipidomics Analysis Service Revenue Trends by Type

4.1.1 Global Historical and Forecasted Revenue by Type (2020-2031)

4.1.2 Global Revenue Market Share by Type (2020-2031)

4.2 Key Product Attributes and Differentiation

4.3 Subtype Dynamics: Growth Leaders, Profitability and Risk

4.3.1 High-Growth Niches and Adoption Drivers

4.3.2 Profitability Hotspots and Cost Drivers

4.3.3 Substitution Threats

5 Global Downstream Application Analysis

5.1 Global Lipidomics Analysis Service Revenue by Application

5.1.1 Global Historical and Forecasted Revenue by Application (2020-2031)

5.1.2 Revenue Market Share by Application (2020-2031)

5.1.3 High-Growth Application Identification

5.1.4 Emerging Application Case Studies

5.2 Downstream Customer Analysis

5.2.1 Top Customers by Region

5.2.2 Top Customers by Application

6 North America

6.1 North America Market Size (2020-2031)

6.2 North America Key Players Revenue in 2024

6.3 North America Lipidomics Analysis Service Market Size by Type (2020-2031)

6.4 North America Lipidomics Analysis Service Market Size by Application (2020-2031)

6.5 North America Growth Accelerators and Market Barriers

6.6 North America Lipidomics Analysis Service Market Size by Country

6.6.1 North America Revenue Trends by Country

6.6.2 US

6.6.3 Canada

6.6.4 Mexico

7 Europe

7.1 Europe Market Size (2020-2031)

7.2 Europe Key Players Revenue in 2024

7.3 Europe Lipidomics Analysis Service Market Size by Type (2020-2031)

7.4 Europe Lipidomics Analysis Service Market Size by Application (2020-2031)

7.5 Europe Growth Accelerators and Market Barriers

7.6 Europe Lipidomics Analysis Service Market Size by Country

7.6.1 Europe Revenue Trends by Country

7.6.2 Germany

7.6.3 France

7.6.4 U.K.

7.6.5 Italy

7.6.6 Russia

8 Asia-Pacific

8.1 Asia-Pacific Market Size (2020-2031)

8.2 Asia-Pacific Key Players Revenue in 2024

8.3 Asia-Pacific Lipidomics Analysis Service Market Size by Type (2020-2031)

8.4 Asia-Pacific Lipidomics Analysis Service Market Size by Application (2020-2031)

8.5 Asia-Pacific Growth Accelerators and Market Barriers

8.6 Asia-Pacific Lipidomics Analysis Service Market Size by Region

8.6.1 Asia-Pacific Revenue Trends by Region

8.7 China

8.8 Japan

8.9 South Korea

8.10 Australia

8.11 India

8.12 Southeast Asia

8.12.1 Indonesia

8.12.2 Vietnam

8.12.3 Malaysia

8.12.4 Philippines

8.12.5 Singapore

9 Central and South America

9.1 Central and South America Market Size (2020-2031)

9.2 Central and South America Key Players Revenue in 2024

9.3 Central and South America Lipidomics Analysis Service Market Size by Type (2020-2031)

9.4 Central and South America Lipidomics Analysis Service Market Size by Application (2020-2031)

9.5 Central and South America Investment Opportunities and Key Challenges

9.6 Central and South America Lipidomics Analysis Service Market Size by Country

9.6.1 Central and South America Revenue Trends by Country (2020 VS 2024 VS 2031)

9.6.2 Brazil

9.6.3 Argentina

10 Middle East and Africa

10.1 Middle East and Africa Market Size (2020-2031)

10.2 Middle East and Africa Key Players Revenue in 2024

10.3 Middle East and Africa Lipidomics Analysis Service Market Size by Type (2020-2031)

10.4 Middle East and Africa Lipidomics Analysis Service Market Size by Application (2020-2031)

10.5 Middle East and Africa Investment Opportunities and Key Challenges

10.6 Middle East and Africa Lipidomics Analysis Service Market Size by Country

10.6.1 Middle East and Africa Revenue Trends by Country (2020 VS 2024 VS 2031)

10.6.2 GCC Countries

10.6.3 Israel

10.6.4 Egypt

10.6.5 South Africa

11 Corporate Profile

11.1 INOMIXO

11.1.1 INOMIXO Corporation Information

11.1.2 INOMIXO Business Overview

11.1.3 INOMIXO Lipidomics Analysis Service Product Features and Attributes

11.1.4 INOMIXO Lipidomics Analysis Service Revenue and Gross Margin (2020-2025)

11.1.5 INOMIXO Lipidomics Analysis Service Revenue by Product in 2024

11.1.6 INOMIXO Lipidomics Analysis Service Revenue by Application in 2024

11.1.7 INOMIXO Lipidomics Analysis Service Revenue by Geographic Area in 2024

11.1.8 INOMIXO Lipidomics Analysis Service SWOT Analysis

11.1.9 INOMIXO Recent Developments

11.2 Lipotype

11.2.1 Lipotype Corporation Information

11.2.2 Lipotype Business Overview

11.2.3 Lipotype Lipidomics Analysis Service Product Features and Attributes

11.2.4 Lipotype Lipidomics Analysis Service Revenue and Gross Margin (2020-2025)

11.2.5 Lipotype Lipidomics Analysis Service Revenue by Product in 2024

11.2.6 Lipotype Lipidomics Analysis Service Revenue by Application in 2024

11.2.7 Lipotype Lipidomics Analysis Service Revenue by Geographic Area in 2024

11.2.8 Lipotype Lipidomics Analysis Service SWOT Analysis

11.2.9 Lipotype Recent Developments

11.3 Mtoz Biolabs

11.3.1 Mtoz Biolabs Corporation Information

11.3.2 Mtoz Biolabs Business Overview

11.3.3 Mtoz Biolabs Lipidomics Analysis Service Product Features and Attributes

11.3.4 Mtoz Biolabs Lipidomics Analysis Service Revenue and Gross Margin (2020-2025)

11.3.5 Mtoz Biolabs Lipidomics Analysis Service Revenue by Product in 2024

11.3.6 Mtoz Biolabs Lipidomics Analysis Service Revenue by Application in 2024

11.3.7 Mtoz Biolabs Lipidomics Analysis Service Revenue by Geographic Area in 2024

11.3.8 Mtoz Biolabs Lipidomics Analysis Service SWOT Analysis

11.3.9 Mtoz Biolabs Recent Developments

11.4 Creative Proteomics

11.4.1 Creative Proteomics Corporation Information

11.4.2 Creative Proteomics Business Overview

11.4.3 Creative Proteomics Lipidomics Analysis Service Product Features and Attributes

11.4.4 Creative Proteomics Lipidomics Analysis Service Revenue and Gross Margin (2020-2025)

11.4.5 Creative Proteomics Lipidomics Analysis Service Revenue by Product in 2024

11.4.6 Creative Proteomics Lipidomics Analysis Service Revenue by Application in 2024

11.4.7 Creative Proteomics Lipidomics Analysis Service Revenue by Geographic Area in 2024

11.4.8 Creative Proteomics Lipidomics Analysis Service SWOT Analysis

11.4.9 Creative Proteomics Recent Developments

11.5 MetwareBio

11.5.1 MetwareBio Corporation Information

11.5.2 MetwareBio Business Overview

11.5.3 MetwareBio Lipidomics Analysis Service Product Features and Attributes

11.5.4 MetwareBio Lipidomics Analysis Service Revenue and Gross Margin (2020-2025)

11.5.5 MetwareBio Lipidomics Analysis Service Revenue by Product in 2024

11.5.6 MetwareBio Lipidomics Analysis Service Revenue by Application in 2024

11.5.7 MetwareBio Lipidomics Analysis Service Revenue by Geographic Area in 2024

11.5.8 MetwareBio Lipidomics Analysis Service SWOT Analysis

11.5.9 MetwareBio Recent Developments

11.6 AxisPharm

11.6.1 AxisPharm Corporation Information

11.6.2 AxisPharm Business Overview

11.6.3 AxisPharm Lipidomics Analysis Service Product Features and Attributes

11.6.4 AxisPharm Lipidomics Analysis Service Revenue and Gross Margin (2020-2025)

11.6.5 AxisPharm Recent Developments

11.7 General Metabolics

11.7.1 General Metabolics Corporation Information

11.7.2 General Metabolics Business Overview

11.7.3 General Metabolics Lipidomics Analysis Service Product Features and Attributes

11.7.4 General Metabolics Lipidomics Analysis Service Revenue and Gross Margin (2020-2025)

11.7.5 General Metabolics Recent Developments

11.8 BGI Genomics

11.8.1 BGI Genomics Corporation Information

11.8.2 BGI Genomics Business Overview

11.8.3 BGI Genomics Lipidomics Analysis Service Product Features and Attributes

11.8.4 BGI Genomics Lipidomics Analysis Service Revenue and Gross Margin (2020-2025)

11.8.5 BGI Genomics Recent Developments

11.9 Cambridge Bioscience

11.9.1 Cambridge Bioscience Corporation Information

11.9.2 Cambridge Bioscience Business Overview

11.9.3 Cambridge Bioscience Lipidomics Analysis Service Product Features and Attributes

11.9.4 Cambridge Bioscience Lipidomics Analysis Service Revenue and Gross Margin (2020-2025)

11.9.5 Cambridge Bioscience Recent Developments

11.10 CD Genomics

11.10.1 CD Genomics Corporation Information

11.10.2 CD Genomics Business Overview

11.10.3 CD Genomics Lipidomics Analysis Service Product Features and Attributes

11.10.4 CD Genomics Lipidomics Analysis Service Revenue and Gross Margin (2020-2025)

11.10.5 Company Ten Recent Developments

12 Lipidomics Analysis ServiceIndustry Chain Analysis

12.1 Lipidomics Analysis Service Industry Chain

12.2 Upstream Analysis

12.2.1 Upstream Key Suppliers

12.3 Middlestream Analysis

12.4 Downstream Sales Model and Distribution Networks

12.4.1 Sales Channels

12.4.2 Distributors

13 Lipidomics Analysis Service Market Dynamics

13.1 Industry Trends and Evolution

13.2 Market Growth Drivers and Emerging Opportunities

13.3 Market Challenges, Risks, and Restraints

14 Key Findings in the Global Lipidomics Analysis Service Study

15 Appendix

15.1 Research Methodology

15.1.1 Methodology/Research Approach

15.1.1.1 Research Programs/Design

15.1.1.2 Market Size Estimation

15.1.1.3 Market Breakdown and Data Triangulation

15.1.2 Data Source

15.1.2.1 Secondary Sources

15.1.2.2 Primary Sources

15.2 Author Details

FEATURED COMPANIES

List of Tables

Table 1. Global Lipidomics Analysis Service Market Size Growth Rate by Type, 2020 VS 2024 VS 2031 (US$ Million)

Table 2. Global Lipidomics Analysis Service Market Size Growth Rate by Application, 2020 VS 2024 VS 2031 (US$ Million)

Table 3. Global Lipidomics Analysis Service Revenue Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)

Table 4. Global Lipidomics Analysis Service Revenue by Region (2020-2025) & (US$ Million)

Table 5. Global Lipidomics Analysis Service Revenue by Region (2026-2031) & (US$ Million)

Table 6. Emerging Market Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)

Table 7. Global Lipidomics Analysis Service Revenue by Players (2020-2025) & (US$ Million)

Table 8. Global Lipidomics Analysis Service Revenue Market Share by Players (2020-2025)

Table 9. Global Key Players’Ranking Shift (2023 vs. 2024) (Based on Revenue)

Table 10. Global Lipidomics Analysis Service by Player Tier (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Lipidomics Analysis Service as of 2024)

Table 11. Global Lipidomics Analysis Service Average Gross Margin (%) by Player (2020 VS 2024)

Table 12. Global Lipidomics Analysis Service Companies Headquarters

Table 13. Global Lipidomics Analysis Service Market Concentration Ratio (CR5 and HHI)

Table 14. Key Market Entrant/Exit (2020-2024) – Drivers & Impact Analysis

Table 15. Key Mergers & Acquisitions, Expansion Plans, R&D Investment

Table 16. Global Lipidomics Analysis Service Revenue by Type (2020-2025) & (US$ Million)

Table 17. Global Lipidomics Analysis Service Revenue by Type (2026-2031) & (US$ Million)

Table 18. Key Product Attributes and Differentiation

Table 19. Global Lipidomics Analysis Service Revenue by Application (2020-2025) & (US$ Million)

Table 20. Global Lipidomics Analysis Service Revenue by Application (2026-2031) & (US$ Million)

Table 21. Lipidomics Analysis Service High-Growth Sectors Demand CAGR (2024-2031)

Table 22. Top Customers by Region

Table 23. Top Customers by Application

Table 24. North America Lipidomics Analysis Service Growth Accelerators and Market Barriers

Table 25. North America Lipidomics Analysis Service Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)

Table 26. Europe Lipidomics Analysis Service Growth Accelerators and Market Barriers

Table 27. Europe Lipidomics Analysis Service Revenue Grow Rate (CAGR) by Country: 2020 VS 2024 VS 2031 (US$ Million)

Table 28. Asia-Pacific Lipidomics Analysis Service Growth Accelerators and Market Barriers

Table 29. Asia-Pacific Lipidomics Analysis Service Revenue Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)

Table 30. Central and South America Lipidomics Analysis Service Investment Opportunities and Key Challenges

Table 31. Central and South America Lipidomics Analysis Service Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)

Table 32. Middle East and Africa Lipidomics Analysis Service Investment Opportunities and Key Challenges

Table 33. Middle East and Africa Lipidomics Analysis Service Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)

Table 34. INOMIXO Corporation Information

Table 35. INOMIXO Description and Major Businesses

Table 36. INOMIXO Product Features and Attributes

Table 37. INOMIXO Revenue (US$ Million) and Gross Margin (2020-2025)

Table 38. INOMIXO Revenue Proportion by Product in 2024

Table 39. INOMIXO Revenue Proportion by Application in 2024

Table 40. INOMIXO Revenue Proportion by Geographic Area in 2024

Table 41. INOMIXO Lipidomics Analysis Service SWOT Analysis

Table 42. INOMIXO Recent Developments

Table 43. Lipotype Corporation Information

Table 44. Lipotype Description and Major Businesses

Table 45. Lipotype Product Features and Attributes

Table 46. Lipotype Revenue (US$ Million) and Gross Margin (2020-2025)

Table 47. Lipotype Revenue Proportion by Product in 2024

Table 48. Lipotype Revenue Proportion by Application in 2024

Table 49. Lipotype Revenue Proportion by Geographic Area in 2024

Table 50. Lipotype Lipidomics Analysis Service SWOT Analysis

Table 51. Lipotype Recent Developments

Table 52. Mtoz Biolabs Corporation Information

Table 53. Mtoz Biolabs Description and Major Businesses

Table 54. Mtoz Biolabs Product Features and Attributes

Table 55. Mtoz Biolabs Revenue (US$ Million) and Gross Margin (2020-2025)

Table 56. Mtoz Biolabs Revenue Proportion by Product in 2024

Table 57. Mtoz Biolabs Revenue Proportion by Application in 2024

Table 58. Mtoz Biolabs Revenue Proportion by Geographic Area in 2024

Table 59. Mtoz Biolabs Lipidomics Analysis Service SWOT Analysis

Table 60. Mtoz Biolabs Recent Developments

Table 61. Creative Proteomics Corporation Information

Table 62. Creative Proteomics Description and Major Businesses

Table 63. Creative Proteomics Product Features and Attributes

Table 64. Creative Proteomics Revenue (US$ Million) and Gross Margin (2020-2025)

Table 65. Creative Proteomics Revenue Proportion by Product in 2024

Table 66. Creative Proteomics Revenue Proportion by Application in 2024

Table 67. Creative Proteomics Revenue Proportion by Geographic Area in 2024

Table 68. Creative Proteomics Lipidomics Analysis Service SWOT Analysis

Table 69. Creative Proteomics Recent Developments

Table 70. MetwareBio Corporation Information

Table 71. MetwareBio Description and Major Businesses

Table 72. MetwareBio Product Features and Attributes

Table 73. MetwareBio Revenue (US$ Million) and Gross Margin (2020-2025)

Table 74. MetwareBio Revenue Proportion by Product in 2024

Table 75. MetwareBio Revenue Proportion by Application in 2024

Table 76. MetwareBio Revenue Proportion by Geographic Area in 2024

Table 77. MetwareBio Lipidomics Analysis Service SWOT Analysis

Table 78. MetwareBio Recent Developments

Table 79. AxisPharm Corporation Information

Table 80. AxisPharm Description and Major Businesses

Table 81. AxisPharm Product Features and Attributes

Table 82. AxisPharm Revenue (US$ Million) and Gross Margin (2020-2025)

Table 83. AxisPharm Recent Developments

Table 84. General Metabolics Corporation Information

Table 85. General Metabolics Description and Major Businesses

Table 86. General Metabolics Product Features and Attributes

Table 87. General Metabolics Revenue (US$ Million) and Gross Margin (2020-2025)

Table 88. General Metabolics Recent Developments

Table 89. BGI Genomics Corporation Information

Table 90. BGI Genomics Description and Major Businesses

Table 91. BGI Genomics Product Features and Attributes

Table 92. BGI Genomics Revenue (US$ Million) and Gross Margin (2020-2025)

Table 93. BGI Genomics Recent Developments

Table 94. Cambridge Bioscience Corporation Information

Table 95. Cambridge Bioscience Description and Major Businesses

Table 96. Cambridge Bioscience Product Features and Attributes

Table 97. Cambridge Bioscience Revenue (US$ Million) and Gross Margin (2020-2025)

Table 98. Cambridge Bioscience Recent Developments

Table 99. CD Genomics Corporation Information

Table 100. CD Genomics Description and Major Businesses

Table 101. CD Genomics Product Features and Attributes

Table 102. CD Genomics Revenue (US$ Million) and Gross Margin (2020-2025)

Table 103. CD Genomics Recent Developments

Table 104. Raw Materials Key Suppliers

Table 105. Distributors List

Table 106. Market Trends and Market Evolution

Table 107. Market Drivers and Opportunities

Table 108. Market Challenges, Risks, and Restraints

Table 109. Research Programs/Design for This Report

Table 110. Key Data Information from Secondary Sources

Table 111. Key Data Information from Primary Sources

List of Figures

Figure 1. Lipidomics Analysis Service Product Picture

Figure 2. Global Lipidomics Analysis Service Market Size Growth Rate by Type, 2020 VS 2024 VS 2031 (US$ Million)

Figure 3. Targeted Lipidomics Product Picture

Figure 4. Non-targeted Lipidomics Product Picture

Figure 5. Global Lipidomics Analysis Service Market Size Growth Rate by Application, 2020 VS 2024 VS 2031 (US$ Million)

Figure 6. Disease Research

Figure 7. Drug Development

Figure 8. Others

Figure 9. Lipidomics Analysis Service Report Years Considered

Figure 10. Global Lipidomics Analysis Service Revenue, (US$ Million), 2020 VS 2024 VS 2031

Figure 11. Global Lipidomics Analysis Service Revenue (2020-2031) & (US$ Million)

Figure 12. Global Lipidomics Analysis Service Revenue (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)

Figure 13. Global Lipidomics Analysis Service Revenue Market Share by Region (2020-2031)

Figure 14. Global Lipidomics Analysis Service Revenue Market Share Ranking (2024)

Figure 15. Tier Distribution by Revenue Contribution (2020 VS 2024)

Figure 16. Targeted Lipidomics Revenue Market Share by Player in 2024

Figure 17. Non-targeted Lipidomics Revenue Market Share by Player in 2024

Figure 18. Global Lipidomics Analysis Service Revenue Market Share by Type (2020-2031)

Figure 19. Global Lipidomics Analysis Service Revenue Market Share by Application (2020-2031)

Figure 20. North America Lipidomics Analysis Service Revenue YoY (2020-2031) & (US$ Million)

Figure 21. North America Top 5 Players Lipidomics Analysis Service Revenue (US$ Million) in 2024

Figure 22. North America Lipidomics Analysis Service Revenue (US$ Million) by Type (2020 - 2031)

Figure 23. North America Lipidomics Analysis Service Revenue (US$ Million) by Application (2020-2031)

Figure 24. US Lipidomics Analysis Service Revenue (2020-2031) & (US$ Million)

Figure 25. Canada Lipidomics Analysis Service Revenue (2020-2031) & (US$ Million)

Figure 26. Mexico Lipidomics Analysis Service Revenue (2020-2031) & (US$ Million)

Figure 27. Europe Lipidomics Analysis Service Revenue YoY (2020-2031) & (US$ Million)

Figure 28. Europe Top 5 Players Lipidomics Analysis Service Revenue (US$ Million) in 2024

Figure 29. Europe Lipidomics Analysis Service Revenue (US$ Million) by Type (2020-2031)

Figure 30. Europe Lipidomics Analysis Service Revenue (US$ Million) by Application (2020-2031)

Figure 31. Germany Lipidomics Analysis Service Revenue (2020-2031) & (US$ Million)

Figure 32. France Lipidomics Analysis Service Revenue (2020-2031) & (US$ Million)

Figure 33. U.K. Lipidomics Analysis Service Revenue (2020-2031) & (US$ Million)

Figure 34. Italy Lipidomics Analysis Service Revenue (2020-2031) & (US$ Million)

Figure 35. Russia Lipidomics Analysis Service Revenue (2020-2031) & (US$ Million)

Figure 36. Asia-Pacific Lipidomics Analysis Service Revenue YoY (2020-2031) & (US$ Million)

Figure 37. Asia-Pacific Top 8 Players Lipidomics Analysis Service Revenue (US$ Million) in 2024

Figure 38. Asia-Pacific Lipidomics Analysis Service Revenue (US$ Million) by Type (2020-2031)

Figure 39. Asia-Pacific Lipidomics Analysis Service Revenue (US$ Million) by Application (2020-2031)

Figure 40. Indonesia Lipidomics Analysis Service Revenue (2020-2031) & (US$ Million)

Figure 41. Japan Lipidomics Analysis Service Revenue (2020-2031) & (US$ Million)

Figure 42. South Korea Lipidomics Analysis Service Revenue (2020-2031) & (US$ Million)

Figure 43. Australia Lipidomics Analysis Service Revenue (2020-2031) & (US$ Million)

Figure 44. India Lipidomics Analysis Service Revenue (2020-2031) & (US$ Million)

Figure 45. Indonesia Lipidomics Analysis Service Revenue (2020-2031) & (US$ Million)

Figure 46. Vietnam Lipidomics Analysis Service Revenue (2020-2031) & (US$ Million)

Figure 47. Malaysia Lipidomics Analysis Service Revenue (2020-2031) & (US$ Million)

Figure 48. Philippines Lipidomics Analysis Service Revenue (2020-2031) & (US$ Million)

Figure 49. Singapore Lipidomics Analysis Service Revenue (2020-2031) & (US$ Million)

Figure 50. Central and South America Lipidomics Analysis Service Revenue YoY (2020-2031) & (US$ Million)

Figure 51. Central and South America Top 5 Players Lipidomics Analysis Service Revenue (US$ Million) in 2024

Figure 52. Central and South America Lipidomics Analysis Service Revenue (US$ Million) by Type (2020-2031)

Figure 53. Central and South America Lipidomics Analysis Service Revenue (US$ Million) by Application (2020-2031)

Figure 54. Brazil Lipidomics Analysis Service Revenue (2020-2025) & (US$ Million)

Figure 55. Argentina Lipidomics Analysis Service Revenue (2020-2025) & (US$ Million)

Figure 56. Middle East and Africa Lipidomics Analysis Service Revenue YoY (2020-2031) & (US$ Million)

Figure 57. Middle East and Africa Top 5 Players Lipidomics Analysis Service Revenue (US$ Million) in 2024

Figure 58. South America Lipidomics Analysis Service Revenue (US$ Million) by Type (2020-2031)

Figure 59. Middle East and Africa Lipidomics Analysis Service Revenue (US$ Million) by Application (2020-2031)

Figure 60. GCC Countries Lipidomics Analysis Service Revenue (2020-2025) & (US$ Million)

Figure 61. Israel Lipidomics Analysis Service Revenue (2020-2025) & (US$ Million)

Figure 62. Egypt Lipidomics Analysis Service Revenue (2020-2025) & (US$ Million)

Figure 63. South Africa Lipidomics Analysis Service Revenue (2020-2025) & (US$ Million)

Figure 64. Lipidomics Analysis Service Industry Chain Mapping

Figure 65. Channels of Distribution (Direct Vs Distribution)

Figure 66. Bottom-up and Top-down Approaches for This Report

Figure 67. Data Triangulation

Figure 68. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$4900

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$7350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$9800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

SIMILAR REPORTS

120 Pages

Type: Report

Code: QYRE-Auto-39V17668

Mon Oct 13 00:00:00 UTC 2025

Add to Cart

Global Lipidomics Analysis Service Market Outlook, In‑Depth Analysis & Forecast to 2031

120 Pages

Type: Report

Code: QYRE-Auto-22L19757

Mon Oct 06 00:00:00 UTC 2025

Add to Cart

Global Spatial Transcriptomics Service Market Outlook, In‑Depth Analysis & Forecast to 2031

120 Pages

Type: Report

Code: QYRE-Auto-29Y19622

Thu Oct 02 00:00:00 UTC 2025

Add to Cart

Global Internet Intelligent Elderly Care Service Platform Market Outlook, In‑Depth Analysis & Forecast to 2031

120 Pages

Type: Report

Code: QYRE-Auto-25O19660

Thu Oct 02 00:00:00 UTC 2025

Add to Cart

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions

Global Lipidomics Analysis Service Market Outlook, In‑Depth Analysis & Forecast to 2031

Published Date: October 2025

Report Code: QYRE-Auto-22L19757

Global Lipidomics Analysis Service Market Outlook, In‑Depth Analysis & Forecast to 2031

FEATURED COMPANIES

Lipidomics Analysis Service Market Size

Lipidomics Analysis Service Market

Report Includes:

Scope of Lipidomics Analysis Service Market Report

Chapter Outline

FAQ for this report

How fast is Lipidomics Analysis Service Market growing?

What is the Lipidomics Analysis Service Market size in 2031?

Who are the main players in the Lipidomics Analysis Service Market report?

What are the Application segmentation covered in the Lipidomics Analysis Service Market report?

What are the Type segmentation covered in the Lipidomics Analysis Service Market report?

FEATURED COMPANIES

RELATED REPORTS